Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Nov 23, 2019
Date Accepted: Feb 4, 2020

The final, peer-reviewed published version of this preprint can be found here:

Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial

Robert P, Manera V, Derreumaux A, Ferrandez M, Leone E, Fabre R, Bourgeois J

Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial

J Med Internet Res 2020;22(3):e17167

DOI: 10.2196/17167

PMID: 32159519

PMCID: 7097721

Efficacy of a web application for cognitive training (MeMo) on cognitive and behavioral performance in people with neurocognitive disorders: a randomized clinical trial.

  • Philippe Robert; 
  • Valeria Manera; 
  • Alexandre Derreumaux; 
  • Marion Ferrandez; 
  • Elsa Leone; 
  • Roxanne Fabre; 
  • Jeremy Bourgeois

ABSTRACT

Background:

Cognitive and behavioral symptoms are the clinical hallmarks of Neurocognitive disorders. Cognitive training may be offered to reduce the risk of cognitive decline and/or dementia. Information and Communication Technologies (ICT) including Serious Games can be useful in improving playful aspect of computerized cognitive training and providing motivating solutions to elderly patients.

Objective:

The objective of the present study was to assess the effectiveness of employing the MeMo web application on cognitive and behavioral symptoms in patients suffering from Neurocognitive disorders.

Methods:

MeMo (Memory Motivation) is a web application that can be used on any web browser (computer or tablet). The training activities proposed in MeMo are divided in three parts; memory, mental flexibility and attention. 46 subjects (mean age 79.4 years) with a diagnosis of Neurocognitive disorders were recruited at the Institut Claude Pompidou Memory Center in Nice. This randomized controlled study compared the evolution of cognition and behavior between patients not using MeMo (control group), and patients using MeMo (Memo group) for 12 weeks, 4 sessions per week. Patients underwent memory and attention tests as well as an apathy assessment at baseline (BL), after 12 weeks (W12 = end of the training period) and after 24 weeks (W 24 = 12 week after the end of the training sessions). In addition, in order to assess the impact of high vs low game use, the population was divided in subjects who used MeMo according to the instructions (about once every 2 days; “Active MeMo subjects”) and those who used it less (Non-active MeMo subjects).

Results:

When comparing cognitive and behavioral scores between baseline, W12 and W24 mixed model analysis for each cognitive and behavioral score indicated no significant interaction between testing time and group. The Active Memo subjects (n = 9) compared to the “Non-active” MeMo subjects (n = 13) showed a significant improvement in 2 attention tests (TMT A (p = 0.045) and correct DSST items (p = 0.045)) and in the Apathy Inventory (p = 0.022). Mixed analysis (time BL, W12, W24 x number of active days) indicated only one significant interaction for the apathy inventory score (p value = 0.010) with a significant increase in apathy in the non-active subjects.

Conclusions:

This study indicates that the cognitive and behavioral efficacy of MeMo - a web-based training application – can be observed only with a regular use of the application. Improvement were observed concerning attention and motivation. Clinical Trial: NCT04142801


 Citation

Please cite as:

Robert P, Manera V, Derreumaux A, Ferrandez M, Leone E, Fabre R, Bourgeois J

Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial

J Med Internet Res 2020;22(3):e17167

DOI: 10.2196/17167

PMID: 32159519

PMCID: 7097721

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.